STOCK TITAN

Outlook Therapeutics: CVI reports 7.9% warrant stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Outlook Therapeutics, Inc. (OTLK) reports that CVI Investments, Inc. beneficially owns 21,000,000 shares, or 7.9% of the common stock. Heights Capital Management, Inc., CVI’s investment manager, reports shared voting and dispositive power over the same shares; the two reports do not represent separate blocks. The reported shares are issuable upon warrant exercise, and both reporting persons disclaim beneficial ownership except for their pecuniary interest.

Some warrants are not exercisable to the extent aggregated beneficial ownership would exceed 4.99%; the remaining warrants are subject to a 9.99% threshold. The company’s quarterly report indicated 243,447,554 shares outstanding as of August 14, 2026. Sarah Travis, Assistant General Counsel and Assistant Secretary of Heights Capital Management, signed; Heights Capital Management serves as CVI’s authorized agent.

Beneficially owned shares 21,000,000 shares CVI Investments and Heights Capital Management reported the same shares; they are issuable upon warrant exercise.
Reported ownership 7.9% Percentage of the class reported by each reporting person.
Warrant exercise threshold 4.99% Some warrants are not exercisable to the extent aggregated beneficial ownership would exceed this threshold.
Warrant exercise threshold 9.99% The remaining warrants are subject to this aggregated beneficial-ownership threshold.
Shares outstanding 243,447,554 shares As of August 14, 2026, according to the company’s quarterly report.
warrants technical
"Shares issuable upon the exercise of warrants to purchase Shares"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.
beneficial ownership regulatory
"Each of the Reporting Persons hereby disclaims any beneficial ownership"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
pecuniary interest financial
"except for their pecuniary interest therein"
Section 13(d) of the Exchange Act regulatory
"for purposes of Section 13(d) of the Exchange Act"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many OTLK shares did CVI Investments report owning?

CVI Investments, Inc. reported 21,000,000 shares beneficially owned, or 7.9% of Outlook Therapeutics’ common stock. Heights Capital Management, Inc. reported shared voting and dispositive power over the same shares as CVI’s investment manager, so the two entries do not represent separate blocks.

What limits apply to the OTLK warrants?

Some warrants are not exercisable to the extent the reporting persons, their affiliates and other persons whose ownership is aggregated would exceed 4.99%; the remaining warrants are subject to a 9.99% threshold on that same aggregated basis.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





69012T305

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: With respect to Row 6 and Row 8 above, Heights Capital Management, Inc. is the investment manager to CVI Investments, Inc. and as such may exercise voting and dispositive power over the shares reported as beneficially owned by CVI Investments, Inc. herein.


SCHEDULE 13G




Comment for Type of Reporting Person: With respect to Row 6 and Row 8 above, Heights Capital Management, Inc. is the investment manager to CVI Investments, Inc. and as such may exercise voting and dispositive power over the shares reported as beneficially owned by CVI Investments, Inc. herein.


SCHEDULE 13G



CVI Investments, Inc.
Signature:/s/ Sarah Travis
Name/Title:Sarah Travis, Assistant General Counsel and Assistant Secretary of Heights Capital Management, Inc.
Date:11/12/2026
Heights Capital Management, Inc.
Signature:/s/ Sarah Travis
Name/Title:Sarah Travis, Assistant General Counsel and Assistant Secretary
Date:11/12/2026

Comments accompanying signature: Heights Capital Management, Inc. serves as authorized agent of CVI Investments, Inc. pursuant to a Limited Power of Attorney, a copy of which was previously filed.
Exhibit Information

EXHIBIT INDEX EXHIBIT DESCRIPTION 24 Limited Power of Attorney* 99 Joint Filing Agreement* * Previously filed

Keep reading